share_log

12 Health Care Stocks Moving In Monday's After-Market Session

Benzinga Real-time News ·  2022/01/31 16:55

Gainers

  • Oncternal Therapeutics (NASDAQ:ONCT) shares moved upwards by 7.0% to $2.0 during Monday's after-market session. The company's market cap stands at $98.8 million.
  • CNS Pharmaceuticals (NASDAQ:CNSP) shares increased by 5.25% to $0.63. The market value of their outstanding shares is at $17.6 million.
  • Viracta Therapeutics (NASDAQ:VIRX) shares rose 4.47% to $2.8. The market value of their outstanding shares is at $104.4 million.
  • Protagenic Therapeutics (NASDAQ:PTIX) stock moved upwards by 4.46% to $1.17. The company's market cap stands at $19.8 million.
  • Minerva Neurosciences (NASDAQ:NERV) stock rose 4.19% to $0.86. The market value of their outstanding shares is at $36.7 million.
  • Vaccinex (NASDAQ:VCNX) stock increased by 3.97% to $1.57. Vaccinex's trading volume hit 463.4K shares by close, accounting for 47.8% of its average volume over the last 100 days. The market value of their outstanding shares is at $48.3 million.

Losers

  • Sio Gene Therapies (NASDAQ:SIOX) stock fell 6.8% to $1.09 during Monday's after-market session. At the close, Sio Gene Therapies's trading volume reached 73.5K shares. This is 12.6% of its average volume over the last 100 days. The company's market cap stands at $80.1 million.
  • Alaunos Therapeutics (NASDAQ:TCRT) stock fell 5.56% to $1.02. The market value of their outstanding shares is at $220.4 million.
  • Calithera Biosciences (NASDAQ:CALA) stock decreased by 5.39% to $0.61. Calithera Biosciences's trading volume hit 710.8K shares by close, accounting for 34.8% of its average volume over the last 100 days. The market value of their outstanding shares is at $46.0 million.
  • Biofrontera (NASDAQ:BFRI) stock decreased by 4.13% to $3.25. The market value of their outstanding shares is at $48.9 million.
  • NeuroBo Pharmaceuticals (NASDAQ:NRBO) shares decreased by 3.85% to $1.0. The company's market cap stands at $26.5 million.
  • 2seventy bio (NASDAQ:TSVT) stock fell 3.17% to $18.08. The company's market cap stands at $422.5 million. See Also:

This article was generated by Benzinga's automated content engine and reviewed by an editor.

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする